ZLT-85593-96384

3 vaccinations 7 coded responses 38 check-ins 7 free-text entries 3 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 309 / GA
Registered: 2021-02-10

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-10
Registered in v-safe
2021-02-10
Dose 1 — Pfizer-BioNTech
2021-02-10
Survey response — day 0, dose 1
MedDRA: Dizziness — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-11
Survey response — days 1–6 daily, dose 1
MedDRA: Dyspnoea — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness

Free text: Short of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-12
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-02-13
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-02-14
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activities

Adult check-in
2021-02-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-02-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-17
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-02-24
Health check-in — day 14, dose 1
Feeling: Poor

Adult check-in
2021-03-01
Dose 2 — Pfizer-BioNTech
2021-03-01
Health check-in — day 0, dose 2
Feeling: Good · Site: Itching · Nausea

Adult check-in
2021-03-02
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-03
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-03-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-08
Health check-in — day 7, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-03-15
Survey response — day 14, dose 2
MedDRA: Abdominal pain — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Abdominal pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-15
Report sent to call center — day 14, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-22
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-29
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-05
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-12
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-05-31
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-30
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-21
Call 1 — Left Voicemail
2021-12-27
Dose 3 — Pfizer-BioNTech
2021-12-28
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-29
Survey response — days 1–6 daily, dose 3
MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Swelling and tenderness of axillary lymphatic tissue on same side as injection was given.

MedDRA releases: 2024-11 · check-in free text available
2021-12-30
Survey response — days 1–6 daily, dose 3
MedDRA: Amphetamines positive, Drug screen false positive — Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness

Free text: Positive drug test for amphetamines, have not consumed any amphetamines or any other substances that could produce a false positive

MedDRA releases: 2024-11 · check-in free text available
2021-12-31
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-01
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-01-02
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-03
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-01-10
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2022-01-17
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2022-01-24
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-31
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-02-07
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-28
Survey response — 3 months, dose 3
MedDRA: Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Allergies

MedDRA releases: 2024-11 · check-in free text available
2022-03-28
Report sent to call center — 3 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-03-29
Call 1 — Left Voicemail
2022-06-27
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-27
Survey response — 12 months, dose 3
MedDRA: COVID-19, Hypersensitivity, Immunodeficiency, Pre-existing disease, Respiratory syncytial virus infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Began having severe allergies resulting in a need for allergy shots to treat/build immunity. RSV diagnosis november 2022, covid positive 12/26/22

MedDRA releases: 2024-11 · check-in free text available
2022-12-27
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-28
Call 2 — Left Voicemail
2022-12-28
Call 2 — Left Voicemail
2022-12-28
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-10	Pfizer-BioNTech
2	2021-03-01	Pfizer-BioNTech
3	2021-12-27	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-03-15	Unsuccessful
2022-03-28	Unsuccessful
2022-12-27	Unsuccessful

Free text

Release 4 — day 0, dose 1

2021-02-10

Systemic reaction (other): Dizziness

Release 4 — days 1–6 daily, dose 1

2021-02-11

Systemic reaction (other): Short of breath

Release 5 — day 14, dose 2

2021-03-15

Symptoms: Abdominal pain

Release 10 — days 1–6 daily, dose 3

2021-12-29

Systemic reaction (other): Swelling and tenderness of axillary lymphatic tissue on same side as injection was given.

2021-12-30

Systemic reaction (other): Positive drug test for amphetamines, have not consumed any amphetamines or any other substances that could produce a false positive

Release 11 — 3 months, dose 3

2022-03-28

Symptoms: Allergies

Release 12 — 12 months, dose 3

2022-12-27

Symptoms: Began having severe allergies resulting in a need for allergy shots to treat/build immunity. RSV diagnosis november 2022, covid positive 12/26/22

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal pain	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Hypersensitivity	·	·	✓
SD	Immunodeficiency	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SRO	Amphetamines positive	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Drug screen false positive	·	·	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Lymph node pain	·	·	✓
SRO	Lymphadenopathy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release